Pfizer (NYSE:PFE) Days Inventory

: 100.98 (As of Sep. 2023)

View and export this data going back to 1951. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). Pfizer's Average Total Inventories for the three months ended in Sep. 2023 was $10,257 Mil. Pfizer's Cost of Goods Sold for the three months ended in Sep. 2023 was $9,269 Mil. Hence, Pfizer's Days Inventory for the three months ended in Sep. 2023 was 100.98.

The historical rank and industry rank for Pfizer's Days Inventory or its related term are showing as below:

PFE' s Days Inventory Range Over the Past 10 Years
Min: 95.86 Med: 233.25 Max: 330.29
Current: 131.07

During the past 13 years, Pfizer's highest Days Inventory was 330.29. The lowest was 95.86. And the median was 233.25.

PFE's Days Inventory is ranked better than
61.43% of 993 companies
in the Drug Manufacturers industry
Industry Median: 154.72 vs PFE: 131.07

Pfizer's Days Inventory declined from Sep. 2022 (150.25) to Sep. 2023 (100.98).

Inventory Turnover measures how fast the company turns over its inventory within a year. Pfizer's Inventory Turnover for the three months ended in Sep. 2023 was 0.90.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Pfizer's Inventory-to-Revenue for the three months ended in Sep. 2023 was 0.78.

Pfizer Days Inventory Historical Data

The historical data trend for Pfizer's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Inventory

306.35

330.29

324.56

101.13

95.86

Pfizer Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Inventory																150.25	87.46	172.96	279.80	100.98

Competitive Comparison

For the Drug Manufacturers - General subindustry, Pfizer's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pfizer Days Inventory Distribution

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Days Inventory distribution charts can be found below:

* The bar in red indicates where Pfizer's Days Inventory falls into.

Pfizer Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Pfizer's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as

	Days Inventory (A: Dec. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2021 )	+	Total Inventories (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (9059	+	8981)	/	2 )	/	34344	*	365
=	9020					/	34344	*	365
=	95.86

Pfizer's Days Inventory for the quarter that ended in Sep. 2023 is calculated as:

	Days Inventory (Q: Sep. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (10310	+	10204)	/	2 )	/	9269	*	365 / 4
=	10257					/	9269	*	365 / 4
=	100.98

Pfizer (NYSE:PFE) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Pfizer's Inventory Turnover for the three months ended in Sep. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	9269	/	10257
	=	0.90

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Pfizer's Inventory to Revenue for the three months ended in Sep. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	10257	/	13232
	=	0.78

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Pfizer Days Inventory Related Terms

Thank you for viewing the detailed overview of Pfizer's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (NYSE:PFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (NYSE:PFE) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan PFEd:UK 0Q1N:UK PFEB:Germany PFE:Germany PFE:Germany PFE:Germany PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Austria PFE:Argentina

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.

Executives

Christoffel Boshoff	officer: Executive Vice President	66 HUDSON BOULEVARD EAST, NEW YORK NY 10001-2192
David M Denton	officer: Chief Financial Officer & EVP	1000 LOWE'S BOULEVARD, MOORESVILLE NC 28117
William Pao	officer: Executive Vice President	C/O CORPORATE SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Michael Mcdermott	officer: Executive Vice President	C/O PFIZER INC. CORPORATE SECRETARY, 235 EAST 42ND STREET, 235 EAST 42ND STREET NY 10017
Aamir Malik	officer: Executive Vice President	C/O PFIZER INC. CORPORATE SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Carapezzi William R Jr	officer: Executive Vice President	600 MOUNTAIN AVENUE, MURRAY HILL NJ 07921
Payal Sahni	officer: Executive Vice President	ATTN: PFIZER CORP. SECRETARY, 235 EAST 42ND ST., NEW YORK NY 10017
Susan Desmond-hellmann	director	513 PARNASSUS AVENUE, S126, SAN FRANCISCO CA 94143
Susan Hockfield	director	GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Jennifer B. Damico	officer: SVP & Controller	C/O PFIZER INC. CORPORATE SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
James Quincey	director	THE COCA-COLA COMPANY, ONE COCA-COLA PLAZA, ATLANTA GA 30313
Scott Gottlieb	director	MOLECULAR INSIGHT PHARMACEUTICALS, 160 SECOND STREET, CAMBRIDGE MA 02142
Lidia Fonseca	officer: Executive Vice President	358 SOUTH MAIN STREET, BURLINGTON NC 27215
Michael Goettler	officer: Group President	1000 MYLAN BOULEVARD, CANONSBURG PA 15317
Dawn Rogers	officer: Executive Vice President	235 EAST 42ND STREET, NEW YORK NY 10017